These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7212946)

  • 1. Subjective response to antipsychotic drugs.
    Van Putten T; May PR; Marder SR; Wittmann LA
    Arch Gen Psychiatry; 1981 Feb; 38(2):187-90. PubMed ID: 7212946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to antipsychotic medication: the doctor's and the consumer's view.
    Van Putten T; May PR; Marder SR
    Am J Psychiatry; 1984 Jan; 141(1):16-9. PubMed ID: 6691455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once versus thrice daily thiothixene in the treatment of schizophrenic in-patients.
    Lee JH; Branchey M; Haher EJ; Varga E; Simpson GM
    Br J Psychiatry; 1974 Jul; 125(0):73-8. PubMed ID: 4604854
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
    Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
    Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS.
    Bjerkenstedt L; Härnryd C; Grimm V; Gullberg B; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1978 Dec; 226(3):157-72. PubMed ID: 32861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melperone in the treatment of schizophrenia.
    Bjerkenstedt L
    Acta Psychiatr Scand Suppl; 1989; 352():35-9. PubMed ID: 2479227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
    Rickels K; Byrdy H; Valentine J; Postel W; Norstad N; Downing R
    Int Pharmacopsychiatry; 1978; 13(1):50-7. PubMed ID: 342437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective responses to thiothixene and chlorpromzine.
    van Putten T; May PR; Marder SR
    Psychopharmacol Bull; 1980 Jul; 16(3):36-8. PubMed ID: 7403397
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
    Ngui PW; Teo SH
    Singapore Med J; 1971 Aug; 12(4):227-32. PubMed ID: 5129906
    [No Abstract]   [Full Text] [Related]  

  • 13. Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.
    Ayers T; Liberman RP; Wallace CJ
    J Clin Psychopharmacol; 1984 Apr; 4(2):89-93. PubMed ID: 6707245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene.
    Huang CC; Gerhardstein RP; Kim DY; Hollister L
    Int Clin Psychopharmacol; 1987 Jan; 2(1):69-75. PubMed ID: 3312398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology.
    Gervin M; Browne S; Garavan J; Roe M; Larkin C; O'Callaghan E
    Eur Psychiatry; 1999 Nov; 14(7):405-9. PubMed ID: 10683626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-blind evaluation of thiothixene with outpatient schizophrenic children.
    Waizer J; Polizos P; Hoffman SP; Engelhardt DM; Margolis RA
    J Autism Child Schizophr; 1972; 2(4):378-86. PubMed ID: 4679294
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenothiazine-induced decompensation.
    Van Putten T; Mutalipassi LR; Malkin MD
    Arch Gen Psychiatry; 1974 Jan; 30(1):102-5. PubMed ID: 4587065
    [No Abstract]   [Full Text] [Related]  

  • 18. Some clinical and physiologic effects of a thioxanthene derivative, thiothixene (P-4657B), in 20 newly hospitalized male schizophrenics.
    Hekimian LJ; Gershon S; Floyd A
    J Clin Pharmacol J New Drugs; 1967; 7(1):52-7. PubMed ID: 5317542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The initial dysphoric reaction (IDR) to the first dose of neuroleptics].
    Schimmelmann BG; Schacht M; Perro C; Lambert M
    Nervenarzt; 2004 Jan; 75(1):36-43. PubMed ID: 14722660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.